Cover Image

Protective Effects and Mechanisms of Yinchen Linggui Zhugan Decoction in HFD-Induced Nonalcoholic Fatty Liver Disease Rats Based on Network Pharmacology and Experimental Verification

Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease, characterized by excessive accumulation of hepatocyte fat. However, there is no exact and effective pharmacotherapy for NAFLD. Yinchen linggui zhugan decoction (YLZD) has been widely used to treat NAFLD. Nevertheless, its ph...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hui Jiang (Author), Tangyou Mao (Author), Yuyue Liu (Author), Xiang Tan (Author), Zhongmei Sun (Author), Yuan Cheng (Author), Xiao Han (Author), Yang Zhang (Author), Jiali Wang (Author), Lei Shi (Author), Yi Guo (Author), Junxiang Li (Author), Haixiao Han (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A preparation technology of volatile components in Linggui Zhugan decoction based on the transfer of cinnamaldehyde and its anti-gastric ulcer effect
by: Ling Li, et al.
Published: (2023)

Linggui Zhugan Decoction activates the SIRT1-AMPK-PGC1α signaling pathway to improve mitochondrial and oxidative damage in rats with chronic heart failure caused by myocardial infarction
by: Siyi Yu, et al.
Published: (2023)

Qingchang Wenzhong Decoction Accelerates Intestinal Mucosal Healing Through Modulation of Dysregulated Gut Microbiome, Intestinal Barrier and Immune Responses in Mice
by: Zhongmei Sun, et al.
Published: (2021)

Integrated network analysis and metabolomics reveal the molecular mechanism of Yinchen Sini decoction in CCl4-induced acute liver injury
by: Weiwei Zheng, et al.
Published: (2023)

Effect of Different Ratios of Yinchen and Gancao Decoction on ANIT-Treated Cholestatic Liver Injury in Mice and Its Potential Underlying Mechanism
by: Huizong Su, et al.
Published: (2021)

Wendan decoction in the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis
by: Yufeng Zhang, et al.
Published: (2022)

Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Magdalena Mazurek, et al.
Published: (2023)

The Alisma and Rhizoma decoction abates nonalcoholic steatohepatitis-associated liver injuries in mice by modulating oxidative stress and autophagy
by: Lijun Xu, et al.
Published: (2019)

Nonalcoholic Fatty Liver Disease An Update
Published: (2019)

Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease
by: Hu Li, et al.
Published: (2022)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019)

Nonalcoholic Fatty Liver Disease and Ayurveda
by: Sanjeev Sharma, et al.
Published: (2023)

Regular Exercise as a Secondary Practical Treatment for Nonalcoholic Fatty Liver Disease
by: Sechang Oh, et al.
Published: (2018)

Association between Insulin Resistance, Metabolic Syndrome and Nonalcoholic Fatty Liver Disease in Chinese Adults
by: Xin Ying, et al.
Published: (2012)

Association between Insulin Resistance, Metabolic Syndrome and Nonalcoholic Fatty Liver Disease in Chinese Adults
by: Yan Jiang, et al.
Published: (2012)

Traditional Chinese medicine Lingguizhugan decoction ameliorate HFD-induced hepatic-lipid deposition in mice by inhibiting STING-mediated inflammation in macrophages
by: Lin Cao, et al.
Published: (2022)

Nonalcoholic fatty liver disease in children and adolescents
by: Hae Sang Lee
Published: (2024)

Nonalcoholic fatty liver disease: New epidemic
by: Rajkumar P Wadhwa, et al.
Published: (2021)

Nonalcoholic fatty liver disease and portal hypertension
by: Marvin Ryou, et al.
Published: (2020)

Biological Mechanisms and Related Natural Inhibitors of CD36 in Nonalcoholic Fatty Liver
by: Feng Y, et al.
Published: (2022)

Comprehensive Analysis of Fecal Microbiome and Metabolomics in Hepatic Fibrosis Rats Reveal Hepatoprotective Effects of Yinchen Wuling Powder From the Host-Microbial Metabolic Axis
by: Yumeng Zhang, et al.
Published: (2021)

Effects of wogonoside on the inflammatory response and oxidative stress in mice with nonalcoholic fatty liver disease
by: Guangyu Jiang, et al.
Published: (2020)

Point mutation of Ffar1 abrogates fatty acid-dependent insulin secretion, but protects against HFD-induced glucose intolerance
by: Sibylle Sabrautzki, et al.
Published: (2017)

Fatty liver in a child: Looking beyond nonalcoholic fatty liver disease
by: Jaya Agarwal, et al.
Published: (2021)

Protective Effects of Tiaoganquzhi Decoction in Treating inflammatory Injury of Nonalcoholic Fatty liver Disease by Promoting CGI-58 and Inhibiting Expression of NLRP3 Inflammasome
by: Huicun Zhang, et al.
Published: (2022)

Nonalcoholic fatty liver disease and insulin resistance in children
by: Kyungchul Song, et al.
Published: (2023)

Electrocardiographic and echocardiographic changes in nonalcoholic fatty liver disease
by: Ahmed S Elsawaby, et al.
Published: (2019)

Noninvasive diagnosis of pediatric nonalcoholic fatty liver disease
by: Hye Ran Yang
Published: (2013)

Da-Chai-Hu Decoction Ameliorates High Fat Diet-Induced Nonalcoholic Fatty Liver Disease Through Remodeling the Gut Microbiota and Modulating the Serum Metabolism
by: Huantian Cui, et al.
Published: (2020)

The role of microbiome in the pathogenesis of oral-gut-liver axis between periodontitis and nonalcoholic fatty liver disease
by: Tsung-Po Chen, et al.
Published: (2023)

Analysis of the Anti-Tumour Effect of Xuefu Zhuyu Decoction Based on Network Pharmacology and Experimental Verification in Drosophila
by: Sitong Wang, et al.
Published: (2022)

A novel role of CRTC2 in promoting nonalcoholic fatty liver disease
by: Hye-Sook Han, et al.
Published: (2022)

Targeting macrophagic 17β-HSD7 by fenretinide for the treatment of nonalcoholic fatty liver disease
by: Xiaoyu Dong, et al.
Published: (2023)

Herbal drug discovery for the treatment of nonalcoholic fatty liver disease
by: Tingting Yan, et al.
Published: (2020)

Effect of oleoylethanolamide on diet-induced nonalcoholic fatty liver in rats
by: Long Li, et al.
Published: (2015)

The relationship between folic acid and nonalcoholic fatty liver disease
by: Bing'er Xu, et al.
Published: (2024)

Endoplasmic reticulum stress response in nonalcoholic fatty liver disease
by: Arushana Ali, et al.
Published: (2018)

The effect of neuropsychiatric medication on pediatric nonalcoholic fatty liver disease
by: Jamie L. Ryan, et al.
Published: (2022)

The Role of Innate Immune Cells in Nonalcoholic Fatty Liver Disease
by: Marina Nati, et al.
Published: (2021)